| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/27/2010 | EP2147677A1 Eradicating agent for helicobacter pylori |
| 01/27/2010 | EP2147675A1 Agent for stimulating lymphatic drainage |
| 01/27/2010 | EP2147673A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 01/27/2010 | EP2146996A1 Xanthine compounds having a positive allosteric gabab receptor modulator effect |
| 01/27/2010 | EP2146958A1 Process for the preparation of form a of tegaserod |
| 01/27/2010 | EP2146732A1 Methods of treating or preventing emesis using growth hormone secretagogues |
| 01/27/2010 | EP1554286B1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | EP1206563B1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN100585401C Detection method for orally administered formulation for reducing fat and expelling toxins |
| 01/27/2010 | CN100584842C Thiazole derivative |
| 01/27/2010 | CN100584837C Hydroxy stilbene kind compound and its preparation method and application |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584371C Chinese-western medicine composition containing carafate for treating gastric ulcer |
| 01/27/2010 | CN100584360C Chinese medicine composition for treating oral inflammation |
| 01/27/2010 | CN100584353C A medicinal composition for treating oral ulcer and its preparation method |
| 01/27/2010 | CN100584348C Anti-hepatitis medical combination |
| 01/27/2010 | CN100584344C Biological stagnation-removing proprietary Chinese medicine and its producing method |
| 01/27/2010 | CN100584343C Medicine health-care usage of globefish I collagen extraction and preparing process thereof |
| 01/27/2010 | CN100584340C Medicament for preventing and controlling stomach diseases |
| 01/27/2010 | CN100584337C Dispersed tablet of tannic matrine and their preparing method |
| 01/27/2010 | CN100584333C Pharmaceutical composition of liver disease |
| 01/27/2010 | CN100584330C Substituted benzimidazole proton pump inhibitor composition, and its preparing method |
| 01/27/2010 | CN100584329C Anethol trithione soft capsule and preparation method thereof |
| 01/27/2010 | CN100584327C Medication composition in use for treating liver disease |
| 01/27/2010 | CN100584325C Medicine composition containing sodium azulene sulfonate and L-glutamine water-soluble precursor |
| 01/27/2010 | CN100584214C Tropical fruit and vegetable crisp slices and preparation method thereof |
| 01/27/2010 | CN100584207C Agastache mate tea |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652040 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |
| 01/26/2010 | US7652034 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 01/26/2010 | US7652012 2-(R)-(4-fluoro-2-methyl-phenyl)-4-(S)-((8aS)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid [1-(R)-3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide maleate and pharmaceutical compositions thereof |
| 01/26/2010 | US7651698 Prolonged release bioadhesive therapeutic systems |
| 01/26/2010 | CA2499354C Transcription control factor zhx3 |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2434731C Modular infusion device and method |
| 01/26/2010 | CA2422889C Method for the treatment of neurological and neuropsychological disorders |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2350031C N-arylsulfonylamino acid omega-amides |
| 01/21/2010 | WO2010009091A2 Anti-inflammatory and anti-allergy extracts from nettle |
| 01/21/2010 | WO2010008619A2 Extended release pharmaceutical formulations of s-adenosylmethionine |
| 01/21/2010 | WO2010008491A2 Lactose compositions with decreased lactose content |
| 01/21/2010 | WO2010008278A1 Treatment of gut motility disorders |
| 01/21/2010 | WO2010008272A1 Treatment of gut motility disorders |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007651A1 Composition having anti-periodontal disease effect |
| 01/21/2010 | WO2010007034A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/21/2010 | WO2010007032A1 Piperidine based ureas as nk1 antagonists |
| 01/21/2010 | WO2010006635A1 Treatment of inflammatory bowel disease |
| 01/21/2010 | WO2009149279A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 01/21/2010 | WO2009130735A4 Fatty acid derivatives for oral administration endowed with high paia- tability |
| 01/21/2010 | WO2009120799A9 Methods of treating fibrotic disorders |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016440 Alpha-aminoamide derivatives useful as anti-inflammatory agents |
| 01/21/2010 | US20100016357 Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorders and Pain |
| 01/21/2010 | US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 01/21/2010 | US20100016319 Arylmethylene urea derivative and use thereof |
| 01/21/2010 | US20100016297 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| 01/21/2010 | US20100016262 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100016214 Carbohydrates mixture |
| 01/21/2010 | US20100015239 Orally Disintegrating Solid Pharmaceutical Dosage Forms Comprising Delayed-Release Lansoprazole and Methods of Making and Using the Same |
| 01/21/2010 | US20100015224 Programmable buoyant delivery technology |
| 01/21/2010 | US20100015167 in vitro method of screening an individual for metastatic colorectal cancer cells or primary and/or metastatic stomach or esophageal cancer cells; vaccine comprising a protein that comprises human sucrase isomaltase protein |
| 01/21/2010 | US20100015162 treating interleukin-22 (IL-22)-associated disorder such as arthritis or psoriasis by administering the antibody in an amount sufficient to inhibit or reduce immune cell activity in the subject |
| 01/21/2010 | US20100015156 Diagnosis of inflammatory bowel disease in children |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | US20100015121 Inhibiting gs-fdh to modulate no bioactivity |
| 01/21/2010 | US20100015111 Methods And Kits For The Treatment Inhibition, And Maintenance Of Gastrointestinal Disorders |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2750727A1 Treatment of inflammatory bowel diseases with mammal beta defensins |
| 01/21/2010 | CA2730789A1 Treatment of inflammatory bowel diseases with mammal beta defensins |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730225A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/20/2010 | EP2145884A1 Indoledione derivative |
| 01/20/2010 | EP2145615A1 Skin-lightening agent containing equol compound as active ingredient |
| 01/20/2010 | EP2144604A2 Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors |
| 01/20/2010 | EP2144503A1 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists |
| 01/20/2010 | EP2003140B1 Galactose derivative, drug carrier and medicinal composition |
| 01/20/2010 | EP1942914B1 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 01/20/2010 | EP1648880B1 Therapeutic agents useful for treating pain |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1267880B2 Low dose entecavir formulation and use |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | CN100582771C Chinese medicinal soft capsule effective ingredient detection method |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581584C Serine protease inhibitor of Rana grahami, and its application |
| 01/20/2010 | CN100581583C Chinese traditional medicine for external application for treating children's lax |
| 01/20/2010 | CN100581573C Oral Chinese medicine composition medicine for treating constipation |